Cargando…
Myocarditis development after COVID-19 vaccination in an immunodeficient case
Autores principales: | Özdemir, Öner, Şeker, Elif, Dikici, Ümmügülsüm, Güneş, Muhammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Immunological Societies. Published by Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239145/ https://www.ncbi.nlm.nih.gov/pubmed/37276946 http://dx.doi.org/10.1016/j.imlet.2023.06.001 |
Ejemplares similares
-
COVID-19 vaccination rate and side effects in CVID patients over the age of 12
por: Özdemir, Öner, et al.
Publicado: (2022) -
Coinfection between SARS‐CoV‐2 and other respiratory tract viruses
por: Özdemir, Öner, et al.
Publicado: (2022) -
Development of myocarditis and pericarditis after COVID‐19 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023) -
Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis
por: Lai, Francisco Tsz Tsun, et al.
Publicado: (2022) -
Primary immunodeficiency diseases in the newborn
por: Ozdemir, Oner
Publicado: (2021)